Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study
Titel:
Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study
Auteur:
Kószó, Renáta Sántha, Dóra Büdi, László Erfán, József Győrfy, Károly Horváth, Zsolt Kocsis, Judit Landherr, László Hitre, Erika Máhr, Károly Pajkos, Gábor Pápai, Zsuzsanna Kahán, Zsuzsanna